France· FR:62313468
TALOXA 600 mg/5 ml suspension buvable
A felbamate product containing felbamate, registered in France by ORGANON FRANCE. The same ATC class is registered in 9 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Felbamate is registered in 9 of 19 countries.
Countries holding a registration under ATC N03AX10 (felbamate), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Felbamate · ATC N03AX10
9 / 19 countries
- Belgiumprice
- Franceprice
- Germany
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of felbamate costs, country by country.
Normalised to the WHO defined daily dose (2.4 g), the median price runs from $4.40 in United States to $10.58 in Switzerland — a ×2.4 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Felbamate · price per daily dose (2.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$10.58
- IT Italy$9.01
- US United States$4.40 (acquisition cost)
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FELBAMATE
- Manufacturer
- ORGANON FRANCE
- Country
- France (FR)
- ATC code
- N03AX10
- ATC class
- Felbamate
- Defined daily dose
- 2.4 g, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009559158981 flacon(s) en verre de 230 ml avec seringue(s) doseuse(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
267 interactions on record for felbamate.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Felbamate · interactions on record
267 records
- 12 severe
- 221 moderate
- 7 minor
Most severe, free to view
- Levonorgestrel and ethinylestradiolG03AA07severe
- Desogestrel and ethinylestradiolG03AA09severe
- Drospirenone and ethinylestradiolG03AA12severe
- EthinylestradiolG03CA01severe
27 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Felbamate in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFelbamateTaro Pharmaceuticals U.S.A., Inc.
- NetherlandsTaloxa-SUSP 600 mg/5 ml, suspensie voor oraal gebruikEuro Registratie Collectief B.V.
- BelgiumTaloxa-Susp 600 mg/5 mlOrganon Belgium
- SwedenTaloxa 120 mg/ml Oral suspensionNV Organon
- United KingdomFelbamate 600mg tabletsSpecial Order
- ItalyTALOXA*40 cpr 600 mgORGANON ITALIA Srl
- GermanyTaloxaOrganonhealthcare Gmbh
- SwitzerlandTaloxa 600 mg, TablettenOrganon GmbH
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Taloxa
- Belgium · Taloxa-Susp, Taloxa-Tabs
- Germany · Taloxa, Taloxa Saft
- Hungary · Taloxa
- Italy · Taloxa
- Luxembourg · Taloxa-Susp, Taloxa-Tabs
- Netherlands · Taloxa-Susp, Taloxa-Tabs
- Norway · Taloxa
- Portugal · Taloxa
- Sweden · Taloxa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6264eb45-260f-4097-8ecc-4dde8fa40ed2 GET /v1/drugs/6264eb45-260f-4097-8ecc-4dde8fa40ed2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62313468",
"date_amm": "1994-05-16",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "FELBAMATE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "suspension buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about felbamate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.